| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |